Health
Moderna Covid vaccine efficacy falls slightly to 90% in US trial – Yahoo News Australia
US biotech company Moderna announced Covid vaccine is 90 percent effective against all forms of the disease and 95 percent effective against severe disease.
US biotech company Moderna announced Covid vaccine is 90 percent effective against all forms of the disease and 95 percent effective against severe disease.
The new results come from its ongoing Phase 3 clinical trial involving more 30,000 people across the United States, and the headline efficacy figure is a slight decrease from an earlier figure of 94.1 percent published in the New England Journal of Medicine in December.
The new number is based on 900 adjudicated cases of Covid from the study…
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
General21 hours agoDonald Trump and the ghost of Al Capone • Inside Story
-
General13 hours agoFrench far-right supporters rally against Le Pen conviction in Paris
-
Business5 hours ago1 ASX dividend stock down 43% I’d buy right now